2017 Q1 Form 10-Q Financial Statement

#000113754717000022 Filed on May 04, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q1
Revenue $7.633M $6.946M
YoY Change 9.89% 6.19%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $320.0K $360.0K
YoY Change -11.11% 0.0%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $405.0K $335.0K
YoY Change 20.9% 5.68%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $2.926M $2.894M
YoY Change 1.11% 46.31%
Income Tax $1.155M $1.125M
% Of Pretax Income 39.47% 38.87%
Net Earnings $1.771M $1.769M
YoY Change 0.11% 44.06%
Net Earnings / Revenue 23.2% 25.47%
Basic Earnings Per Share $0.10 $0.10
Diluted Earnings Per Share $0.10 $0.10
COMMON SHARES
Basic Shares Outstanding 16.71M shares 16.05M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q1 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $133.1M $125.5M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $10.80M $10.70M
YoY Change 0.93% -5.57%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.200M $1.000M
YoY Change 20.0% 0.0%
Other Assets $3.400M $5.100M
YoY Change -33.33% -25.0%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $784.1M $741.8M
YoY Change 5.7% 9.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.900M $5.100M
YoY Change 15.69% -12.07%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.900M $5.100M
YoY Change 15.69% -12.07%
LONG-TERM LIABILITIES
Long-Term Debt $9.200M $7.900M
YoY Change 16.46% -22.55%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $9.200M $7.900M
YoY Change 16.46% -22.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.900M $5.100M
Total Long-Term Liabilities $9.200M $7.900M
Total Liabilities $685.6M $650.3M
YoY Change 5.42% 9.43%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $98.50M $91.45M
YoY Change
Total Liabilities & Shareholders Equity $784.1M $741.8M
YoY Change 5.7% 9.34%

Cashflow Statement

Concept 2017 Q1 2016 Q1
OPERATING ACTIVITIES
Net Income $1.771M $1.769M
YoY Change 0.11% 44.06%
Depreciation, Depletion And Amortization $320.0K $360.0K
YoY Change -11.11% 0.0%
Cash From Operating Activities $2.430M -$239.0K
YoY Change -1116.74% -111.58%
INVESTING ACTIVITIES
Capital Expenditures -$680.0K -$230.0K
YoY Change 195.65% -269.12%
Acquisitions
YoY Change
Other Investing Activities $24.43M -$15.32M
YoY Change -259.46% -53.46%
Cash From Investing Activities $23.75M -$15.55M
YoY Change -252.8% -52.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$6.082M $15.52M
YoY Change -139.18% 20.37%
NET CHANGE
Cash From Operating Activities $2.430M -$239.0K
Cash From Investing Activities $23.75M -$15.55M
Cash From Financing Activities -$6.082M $15.52M
Net Change In Cash $20.10M -$262.0K
YoY Change -7771.76% -98.55%
FREE CASH FLOW
Cash From Operating Activities $2.430M -$239.0K
Capital Expenditures -$680.0K -$230.0K
Free Cash Flow $3.110M -$9.000K
YoY Change -34655.56% -100.47%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 dei Amendment Flag
AmendmentFlag
false
CY2017Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2017Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017Q1 dei Document Period End Date
DocumentPeriodEndDate
2017-03-31
CY2017Q1 dei Document Type
DocumentType
10-Q
CY2017Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001137547
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16875190 shares
CY2017Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2017Q1 dei Entity Registrant Name
EntityRegistrantName
UNITED SECURITY BANCSHARES
CY2016Q1 ubfo Adjustment Related To Fair Value Calculations Net Of Tax
AdjustmentRelatedToFairValueCalculationsNetOfTax
211000 USD
CY2017Q1 ubfo Adjustment Related To Fair Value Calculations Net Of Tax
AdjustmentRelatedToFairValueCalculationsNetOfTax
-298000 USD
CY2017Q1 ubfo Amount Transferred From Retained Earnings To Common Stocks Based On Closing Price On Declaration Date
AmountTransferredFromRetainedEarningsToCommonStocksBasedOnClosingPriceOnDeclarationDate
1219759 USD
CY2016Q4 ubfo Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses Accumulated In Investments Balance
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLossesAccumulatedInInvestmentsBalance
284000 USD
CY2017Q1 ubfo Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses Accumulated In Investments Balance
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLossesAccumulatedInInvestmentsBalance
252000 USD
CY2016Q4 ubfo Available For Sale Securities Continuous Unrealized Loss Position Aggregate Losses Accumulated In Investments Balance
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAggregateLossesAccumulatedInInvestmentsBalance
755000 USD
CY2017Q1 ubfo Available For Sale Securities Continuous Unrealized Loss Position Aggregate Losses Accumulated In Investments Balance
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAggregateLossesAccumulatedInInvestmentsBalance
640000 USD
CY2017Q1 ubfo Closing Price Of Common Stock On Declaration Date
ClosingPriceOfCommonStockOnDeclarationDate
7.38
CY2017Q1 ubfo Common Stock Dividend Rate Declared
CommonStockDividendRateDeclared
0.01
CY2016Q1 ubfo Financing Receivable Modification Allowance For Loan Losses
FinancingReceivableModificationAllowanceForLoanLosses
1895000 USD
CY2017Q1 ubfo Financing Receivable Modification Allowance For Loan Losses
FinancingReceivableModificationAllowanceForLoanLosses
703000 USD
CY2016Q1 ubfo Financing Receivable Modifications Additions
FinancingReceivableModificationsAdditions
623000 USD
CY2017Q1 ubfo Financing Receivable Modifications Additions
FinancingReceivableModificationsAdditions
1709000 USD
CY2016Q1 ubfo Financing Receivable Modifications Defaults
FinancingReceivableModificationsDefaults
0 USD
CY2017Q1 ubfo Financing Receivable Modifications Defaults
FinancingReceivableModificationsDefaults
0 USD
CY2016Q1 ubfo Financing Receivable Modifications Numberof Contracts During Period2
FinancingReceivableModificationsNumberofContractsDuringPeriod2
4 contract
CY2017Q1 ubfo Financing Receivable Modifications Numberof Contracts During Period2
FinancingReceivableModificationsNumberofContractsDuringPeriod2
3 contract
CY2017Q1 ubfo Financing Receivable Periodof Successful Payment History Usedfor Restructured Loan Accrual Status
FinancingReceivablePeriodofSuccessfulPaymentHistoryUsedforRestructuredLoanAccrualStatus
P6M
CY2016Q4 ubfo Loans Receivables Total Impaired Loans Fair Value Disclosure
LoansReceivablesTotalImpairedLoansFairValueDisclosure
301000 USD
CY2017Q1 ubfo Loans Receivables Total Impaired Loans Fair Value Disclosure
LoansReceivablesTotalImpairedLoansFairValueDisclosure
0 USD
CY2017Q1 ubfo Number Of General Segments For The Segregation Of Portfolio
NumberOfGeneralSegmentsForTheSegregationOfPortfolio
2 segment
CY2017Q1 ubfo Number Of Monthly Payments To Demonstrate Repayment Ability
NumberOfMonthlyPaymentsToDemonstrateRepaymentAbility
6 payment
CY2017Q1 ubfo Number Of Risk Rating Approaches
NumberOfRiskRatingApproaches
2 rating
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2016Q4 us-gaap Assets
Assets
787972000 USD
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
387000 USD
CY2017Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
359000 USD
CY2017Q1 ubfo Numberof Loan Portfolio Segment
NumberofLoanPortfolioSegment
11 segment
CY2017Q1 ubfo Numberof Loans Entity Experienced Losses
NumberofLoansEntityExperiencedLosses
9 loan
CY2017Q1 ubfo Numberof Subsidiaries
NumberofSubsidiaries
2 subsidiary
CY2017Q1 ubfo Percentage Of Stock Dividend Declared On Common Stocks Outstanding
PercentageOfStockDividendDeclaredOnCommonStocksOutstanding
0.01
CY2017Q1 ubfo Period Of Default Minimum
PeriodOfDefaultMinimum
P90D
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21000 shares
CY2017Q1 us-gaap Assets
Assets
784098000 USD
CY2016Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
57792000 USD
CY2017Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
55351000 USD
CY2016Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
57859000 USD
CY2017Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
55632000 USD
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
755000 USD
CY2017Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
640000 USD
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
41901000 USD
CY2017Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
35945000 USD
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
471000 USD
CY2017Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
388000 USD
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
38185000 USD
CY2017Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
32197000 USD
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
3716000 USD
CY2017Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
3748000 USD
CY2016Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
57491000 USD
CY2017Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
55351000 USD
CY2016Q1 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
0 USD
CY2017Q1 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
0 USD
CY2016Q1 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0 USD
CY2017Q1 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
125751000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
125489000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
113032000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
133132000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-262000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
20100000 USD
CY2016Q4 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
113032000 USD
CY2017Q1 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
133132000 USD
CY2016Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2017Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16705294 shares
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16874890 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16705294 shares
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16874890 shares
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1811000 USD
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1831000 USD
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 USD
CY2017Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 USD
CY2016Q4 us-gaap Deposits
Deposits
676629000 USD
CY2017Q1 us-gaap Deposits
Deposits
670541000 USD
CY2016Q4 us-gaap Federal Home Loan Bank Advances Current
FederalHomeLoanBankAdvancesCurrent
0 USD
CY2017Q1 us-gaap Federal Home Loan Bank Advances Current
FederalHomeLoanBankAdvancesCurrent
0 USD
CY2015Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
9713000 USD
CY2016Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
9718000 USD
CY2016Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
8902000 USD
CY2017Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
8948000 USD
CY2016Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
7330000 USD
CY2017Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
7096000 USD
CY2016Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
2388000 USD
CY2017Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
1852000 USD
CY2016Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
-27000 USD
CY2017Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
-25000 USD
CY2016Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
59000 USD
CY2017Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
38000 USD
CY2016Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
32000 USD
CY2017Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
13000 USD
CY2016Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
491391000 USD
CY2016Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
23287000 USD
CY2017Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
529102000 USD
CY2017Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
17739000 USD
CY2016Q1 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
623000 USD
CY2017Q1 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
1709000 USD
CY2016Q1 us-gaap Financing Receivable Modifications Pre Modification Recorded Investment2
FinancingReceivableModificationsPreModificationRecordedInvestment2
726000 USD
CY2017Q1 us-gaap Financing Receivable Modifications Pre Modification Recorded Investment2
FinancingReceivableModificationsPreModificationRecordedInvestment2
1709000 USD
CY2015Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
18508000 USD
CY2016Q1 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
18591000 USD
CY2016Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
12410000 USD
CY2017Q1 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
13429000 USD
CY2016Q1 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
0 contract
CY2017Q1 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
0 contract
CY2016Q1 us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
0 USD
CY2017Q1 us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
0 USD
CY2016Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
1250000 USD
CY2017Q1 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0 USD
CY2016Q4 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
566656000 USD
CY2017Q1 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
544851000 USD
CY2016Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
7264000 USD
CY2017Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
7176000 USD
CY2016Q4 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
3103000 USD
CY2017Q1 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
1990000 USD
CY2016Q1 us-gaap Financing Receivables Impaired Troubled Debt Restructuring Write Down
FinancingReceivablesImpairedTroubledDebtRestructuringWriteDown
540000 USD
CY2017Q1 us-gaap Financing Receivables Impaired Troubled Debt Restructuring Write Down
FinancingReceivablesImpairedTroubledDebtRestructuringWriteDown
690000 USD
CY2016Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
0 USD
CY2017Q1 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
0 USD
CY2016Q1 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
23483000 USD
CY2016 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
19566000 USD
CY2017Q1 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
16958000 USD
CY2016Q1 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
363000 USD
CY2016 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
953000 USD
CY2017Q1 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
223000 USD
CY2016Q1 us-gaap Impaired Financing Receivable Interest Income Cash Basis Method
ImpairedFinancingReceivableInterestIncomeCashBasisMethod
149000 USD
CY2017Q1 us-gaap Impaired Financing Receivable Interest Income Cash Basis Method
ImpairedFinancingReceivableInterestIncomeCashBasisMethod
79000 USD
CY2016Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
16179000 USD
CY2017Q1 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
17739000 USD
CY2016Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
1360000 USD
CY2017Q1 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
1852000 USD
CY2016Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
16144000 USD
CY2017Q1 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
17683000 USD
CY2016Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
8616000 USD
CY2017Q1 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
10247000 USD
CY2016Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
7563000 USD
CY2017Q1 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
7492000 USD
CY2016Q1 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0 USD
CY2017Q1 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0 USD
CY2016 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 USD
CY2017Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 USD
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2894000 USD
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2926000 USD
CY2016Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
6946000 USD
CY2017Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
7633000 USD
CY2016Q1 us-gaap Interest Expense
InterestExpense
335000 USD
CY2017Q1 us-gaap Interest Expense
InterestExpense
405000 USD
CY2016Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
6633000 USD
CY2017Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
7207000 USD
CY2016Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
6611000 USD
CY2017Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
7228000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
691318000 USD
CY2017Q1 us-gaap Liabilities
Liabilities
685600000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
787972000 USD
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
784098000 USD
CY2016Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
8832000 USD
CY2017Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
9171000 USD
CY2017Q1 us-gaap Loans And Leases Receivable Consumer Installment Student
LoansAndLeasesReceivableConsumerInstallmentStudent
39684000 USD
CY2016Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
514678000 USD
CY2016Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
561932000 USD
CY2017Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
538800000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15522000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6082000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15545000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
23752000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-239000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2430000 USD
us-gaap Net Income Loss
NetIncomeLoss
5616000 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
1769000 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
1771000 USD
CY2016Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1769000 USD
CY2017Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1771000 USD
CY2016Q1 us-gaap Noninterest Expense
NoninterestExpense
5300000 USD
CY2017Q1 us-gaap Noninterest Expense
NoninterestExpense
5190000 USD
CY2016Q1 us-gaap Noninterest Income
NoninterestIncome
1561000 USD
CY2017Q1 us-gaap Noninterest Income
NoninterestIncome
909000 USD
CY2016Q4 us-gaap Notes Receivable Net
NotesReceivableNet
132936000 USD
CY2017Q1 us-gaap Notes Receivable Net
NotesReceivableNet
126353000 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-444000 USD
CY2016Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
42000 USD
CY2017Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
60000 USD
CY2016Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
5000 USD
CY2017Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
5000 USD
CY2016Q1 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
71000 USD
CY2017Q1 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
100000 USD
CY2016Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
42000 USD
CY2017Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
60000 USD
CY2016Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Net Unamortized Gain Loss Arising During Period Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
12000 USD
CY2017Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Net Unamortized Gain Loss Arising During Period Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
13000 USD
CY2016Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
59000 USD
CY2017Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
87000 USD
CY2016Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
24000 USD
CY2017Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
35000 USD
CY2016Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
22000 USD
CY2017Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-21000 USD
CY2016Q1 us-gaap Stock Issued1
StockIssued1
787000 USD
CY2017Q1 us-gaap Stock Issued1
StockIssued1
1220000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
22000 USD
CY2016Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
8000 USD
CY2017Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7000 USD
us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
0 USD
CY2016Q1 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
0 USD
CY2017Q1 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
0 USD
CY2017Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6000 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
89635000 USD
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
91454000 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
96654000 USD
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
98498000 USD
CY2016Q4 us-gaap Trading Securities
TradingSecurities
0 USD
CY2017Q1 us-gaap Trading Securities
TradingSecurities
0 USD
CY2016Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3058 shares
CY2017Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
13795 shares

Files In Submission

Name View Source Status
0001137547-17-000022-index-headers.html Edgar Link pending
0001137547-17-000022-index.html Edgar Link pending
0001137547-17-000022.txt Edgar Link pending
0001137547-17-000022-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ubfo-20170331.xml Edgar Link completed
ubfo-20170331.xsd Edgar Link pending
ubfo-2017033110q.htm Edgar Link pending
ubfo-20170331exhibit311.htm Edgar Link pending
ubfo-20170331exhibit312.htm Edgar Link pending
ubfo-20170331exhibit321.htm Edgar Link pending
ubfo-20170331exhibit322.htm Edgar Link pending
ubfo-20170331_cal.xml Edgar Link unprocessable
ubfo-20170331_def.xml Edgar Link unprocessable
ubfo-20170331_lab.xml Edgar Link unprocessable
ubfo-20170331_pre.xml Edgar Link unprocessable